Precigen (PGEN) Interest Coverage Ratio (2012 - 2026)
Precigen's (PGEN) quarterly Interest Coverage Ratio came in at 2.06 in Q1 2026, up 96.21% year-on-year from 1.05 in Q1 2025, and up 71.11% on a QoQ basis from 7.13 in Q4 2025.
Precigen (PGEN) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Interest Coverage Ratio data on file, last reported at 2.06 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 96.21% year-over-year to 2.06 in Q1 2026; TTM through Mar 2026 was 14.76, a 89.03% increase from a year earlier, with the FY2025 full-year figure at 0.28, up 15.19% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.06, up from 7.13 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for PGEN reached as high as 49.53 in Q4 2023 and fell as low as 20937.0 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 1993.4 across 5 years, with a median of 18.43 in 2022.
- On a YoY basis, Interest Coverage Ratio climbed as much as 244.74% in 2023 and fell as far as 559759.89% in 2023.
- Year by year, Interest Coverage Ratio stood at 34.22 in 2022, then jumped by 244.74% to 49.53 in 2023, then sank by 21564.53% to 10631.0 in 2024, then soared by 99.93% to 7.13 in 2025, then soared by 71.11% to 2.06 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 2.06 in Q1 2026, 7.13 in Q4 2025, and 0.92 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -2.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.06 |
| Dec 31, 2025 | -7.13 |
| Sep 30, 2025 | -0.92 |
| Jun 30, 2025 | -25.15 |
| Mar 31, 2025 | -54.32 |
| Sep 30, 2024 | -10,631.00 |
| Jun 30, 2024 | -7.09 |
| Mar 31, 2024 | -42.67 |
| Dec 31, 2023 | 49.53 |
| Sep 30, 2023 | -20,937.00 |
| Jun 30, 2023 | -155.29 |
| Mar 31, 2023 | -25.41 |
| Dec 31, 2022 | -34.22 |
| Sep 30, 2022 | -3.74 |
| Jun 30, 2022 | -11.71 |
| Mar 31, 2022 | -6.27 |
| Dec 31, 2021 | -1.88 |
| Sep 30, 2021 | -4.52 |
| Jun 30, 2021 | -5.66 |
| Mar 31, 2021 | -3.90 |